When Rare is Not Rare: Help Fight Rare Disease, Today and Everyday

Most people have never heard of osteochondrodysplasia, glycogen storage disease, or a thousand other conditions with names we may or may not be able to pronounce. Individually, each of these diseases is extremely rare. Some, like medium chain acyl-coA dehydrogenase deficiency, may affect about one person in ...

Read more

SNPwatch: Association Between FTO Variant and Obesity Depends on Age and Impacts Development

Editor’s note: Pending an FDA decision, 23andMe no longer offers new customers access to health reports referred to in this post. Customers who purchased prior to November 22, 2013 will still be able to see their health reports, but those who purchased after that time will not. Those customers will have ...

Read more

SNPwatch: Researchers Identify Variant Associated with Breast Density

Editor’s note: Pending an FDA decision, 23andMe no longer offers new customers access to health reports referred to in this post. Customers who purchased prior to November 22, 2013 will still be able to see their health reports, but those who purchased after that time will not. Those customers will have ...

Read more

23andMe to Attend FDA Public Advisory Committee Meeting on Direct-to-Consumer Genetic Tests

Last summer, the Food and Drug Administration (FDA) indicated that it would be revising its regulatory guidelines pertaining to laboratory-developed tests (LDTs), and that direct-to-consumer genetic tests such as 23andMe's Personal Genome Service® would potentially fall under that category. 23andMe has ...

Read more

SNPwatch: Researchers Identify Risk Variants Shared by Crohn’s Disease and Celiac Disease

Editor’s note: Pending an FDA decision, 23andMe no longer offers new customers access to health reports referred to in this post. Customers who purchased prior to November 22, 2013 will still be able to see their health reports, but those who purchased after that time will not. Those customers will have ...

Read more

Upgrading to the New Chip? What to Expect.

When we announced the release of our newest genotyping platform and offered an extended holiday sale last year, people who had been waiting for an affordable opportunity to get a glimpse of their genomes jumped at the chance. Existing customers also acted on the news, signing up friends and family and even ...

Read more

23andMe Achieves Milestone in Building Sarcoma Research Community and Announces Appointment of Sarcoma Scientific Advisory Committee

Leading Personal Genomics Company Engages the Worldwide Sarcoma Community for Research and Welcomes Leading Sarcoma Researchers and Clinicians as Advisors 23andMe’s sarcoma research efforts are well underway with collection of both phenotypic and genetic data from 500 individuals diagnosed with sarcoma ...

Read more

PMWC 2011 Delivers an Inspiring Program on Personalized Medicine

More than 800 people packed the auditorium in Silicon Valley’s Computer History Museum for two days this week listening to the impassioned words of the greatest thinkers, movers, and shakers in personalized medicine. It’s a topic that’s easy to get behind -- who doesn’t think that medical care tailored to the ...

Read more

Health at 23andMe: The Circus of Human Traits

Editor’s note: Pending an FDA decision, 23andMe no longer offers new customers access to health reports referred to in this post. Customers who received their health information prior to November 22, 2013 will still be able to see their health reports, but those who purchased after that time will only have ...

Read more

Our Top Ten for 2010

2010 was a big year in more ways than one! Research uncovered more genetic variants associated with common diseases, fascinating portraits of our early ancestors, and new insights into the genetic diversity of modern populations. And on top of all that, 23andMe published its first research discoveries, ...

Read more

Return to top